EUVIMEDEUVIMED entdecken
Fallbericht

Successful treatment of pustulotic arthro-osteitis with bimekizumab: a case report

Masahiro Kogami iD, Rina Takahashi, Ryosuke Shirayanagi, Wataru Nakamura, Takumi Saito, Ayako Makiyama, Yoshiyuki Abe, Kurisu Tada, Ken Yamaji, Naoto Tamura

Modern Rheumatology Case Reports · 2025

DOI: 10.1093/mrcr/rxaf078 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Modern Rheumatology Case Reports, 2025. Verfasst von Masahiro Kogami und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Osteitis, Psoriasis. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pustulotic arthro-osteitis (PAO) is an inflammatory osteoarticular disorder associated with palmoplantar pustulosis (PPP). Whilst anti-TNF-α agents and IL-23 inhibitors have shown efficacy in PAO, the therapeutic potential of bimekizumab (BKZ), a dual IL-17A and IL-17F inhibitor, remains unestablished. A 53-year-old Japanese man with a history of PPP developed fever and polyarthritis involving the distal interphalangeal joints, shoulders, and knees. Laboratory investigations revealed elevated inflammatory markers, including C-reactive protein and matrix metalloproteinase-3. Imaging studies showed inflammation of the sternum and sacroiliac joints, consistent with PAO. Despite treatment with nonsteroidal anti-inflammatory drugs, methotrexate, adalimumab, and upadacitinib, his symptoms and systemic inflammation persisted. Bacterial cultures were negative, and no other causes of fever were identified. The patient became afebrile the day after switching to BKZ, and both joint and skin symptoms gradually improved thereafter, along with normalisation of laboratory markers. This case highlights the potential utility of BKZ in the treatment of refractory PAO, particularly in cases with systemic inflammation and fever.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedOsteitisPsoriasisHumansMaleMiddle AgedTreatment Outcome

Stichwörter der Autor:innen

Pustulotic arthro-osteitisbimekizumabinterleukin-17

Substanzen

Antibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan.

ORCID-Profile: Masahiro Kogami

Zitieren

APA

Kogami, M., Takahashi, R., Shirayanagi, R., Nakamura, W., Saito, T., Makiyama, A., Abe, Y., Tada, K., Yamaji, K., & Tamura, N. (2025). Successful treatment of pustulotic arthro-osteitis with bimekizumab: a case report. Modern Rheumatology Case Reports. https://doi.org/10.1093/mrcr/rxaf078

Vancouver

Kogami M, Takahashi R, Shirayanagi R, Nakamura W, Saito T, Makiyama A, et al. Successful treatment of pustulotic arthro-osteitis with bimekizumab: a case report. Modern Rheumatology Case Reports. 2025. doi:10.1093/mrcr/rxaf078

BibTeX
@article{Kogami2025,
  author = {Kogami, Masahiro and Takahashi, Rina and Shirayanagi, Ryosuke and Nakamura, Wataru and Saito, Takumi and Makiyama, Ayako and Abe, Yoshiyuki and Tada, Kurisu and Yamaji, Ken and Tamura, Naoto},
  title = {Successful treatment of pustulotic arthro-osteitis with bimekizumab: a case report},
  journal = {Modern Rheumatology Case Reports},
  year = {2025},
  doi = {10.1093/mrcr/rxaf078}
}
Kostenlos starten →